Cortical structure alterations in toddlers with different severities of congenital heart disease: a cross-sectional

Fan Lu1, Yuting Liu1, Sizhe Lu2

  • 1Department of Radiology, Children's Hospital of Nanjing Medical University, Nanjing, 210019, Jiangsu Province, China.

Insights

Toddlers with congenital heart disease (CHD) show altered cortical structure, even in mild cases. These brain changes are linked to neurodevelopmental outcomes and hemoglobin levels, suggesting early intervention targets.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pediatric Cardiology

Background:

  • Neurodevelopmental risks in complex congenital heart disease (CHD) are known, but less is understood about mild CHD's neuroanatomical effects.
  • This study investigates cortical structure in toddlers with varying CHD severities and its relation to neurodevelopment.

Purpose of the Study:

  • To characterize cortical structure in toddlers with congenital heart disease (CHD) across different severities.
  • To explore associations between cortical structure, preoperative laboratory values, and neurodevelopmental outcomes in these children.

Main Methods:

  • Magnetic resonance imaging (MRI) was used to assess cortical structure (grey matter volume and thickness) in 109 toddlers with CHD and 56 healthy controls (HCs).
  • Gesell Developmental Schedules were administered to CHD toddlers, who were stratified by CHD severity.
  • Generalized linear models analyzed differences in cortical structure and relationships with laboratory values and neurodevelopment.

Main Results:

  • Toddlers with mild and moderate-to-severe CHD showed reduced total brain volume and grey matter volume (GMV) compared to HCs.
  • Significant reductions in cortical GMV and thickness were found in specific brain regions across all CHD severity groups.
  • Altered cortical structures correlated with neurodevelopmental domains (adaptive, gross motor, fine motor skills) and hemoglobin levels.

Conclusions:

  • Congenital heart disease (CHD) is associated with variations in grey matter volume and cortical thickness, irrespective of disease severity.
  • Mild CHD cases exhibited cortical alterations comparable to moderate-to-severe cases, highlighting the need for early neurodevelopmental consideration.
  • Cortical structure may serve as a neuroimaging marker linking preoperative factors to neurodevelopmental outcomes, indicating potential intervention targets.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...